Generate a tailored SOP for Dr. Paul Mckay. Improve your application with a focused, well-structured draft.
Paul McKay is a senior researcher working in Professor Robin Shattock’s mucosal vaccinology team at the Department of Infectious Diseases. His primary research focuses on the development of new vaccine candidates and therapeutic agents, particularly self-amplifying mRNA approaches. His work investigates the expression of transgenes and the resulting immune responses, impacting human health outcomes. Paul has authored over 100 publications and is an inventor on 10 patents. He is also a co-founder of an Imperial College Biotech Start-up, which operates within a large collaborative network. Paul earned his B.Sc. (Hons) in Biochemistry from Imperial College, followed by an M.Sc. in Medical Immunology from the Royal Postgraduate Medical School (now Hammersmith Campus, Imperial College, London) and a Ph.D. in Molecular Immunology from Imperial College. Additionally, he spent four years at Harvard Medical School and Beth Israel Deaconess Medical Centre in Boston, USA, working with Professor Norman Letvin on the characterization of T cell responses and the analysis, development, and optimization of DNA prime recombinant vector boost HIV vaccine candidates.
Specialisms available in Materials for the Energy Transition or Theory and Simulation of Materials.